Yabe et al. [11] performed OGTT and MMTT on healthy individuals, patients with impaired glucose tolerance, and diabetes patients and concluded that glucagon is not associated with response to incretin based on the findings that glucagon was increased to a greater extent in diabetes patients, whereas there was no difference in GLP-1 and GIP levels among the three groups. The gene discussed is GLP1R; the disease is diabetes mellitus.